Truist and RBC Capital Raise Price Targets on Intuitive Surgical (ISRG)

Company Overview - Intuitive Surgical, Inc. (NASDAQ:ISRG) is a medical device and technology company that designs and manufactures robotic-assisted surgical systems aimed at making surgery less invasive [5]. Price Target Increases - Truist raised its price target on Intuitive Surgical from $620 to $650 while maintaining a Buy rating [1]. - RBC Capital also increased its price target on Intuitive Surgical from $625 to $650 and maintained an Outperform rating [3]. Industry Outlook - Truist has a positive outlook for the MedTech industry heading into 2026, citing a more attractive relative sector valuation [2]. - RBC Capital anticipates a year of positive momentum for the Medical Supplies & Devices sector, driven by strong fundamentals such as aging populations, improved global healthcare access, and innovation [4]. Product Feedback - Intuitive Surgical is receiving positive feedback on its da Vinci 5 (dV5) system, with improvements noted in precision, imaging, ergonomics, and integration, which are enhancing efficiency [4].